Damn them Brazillions!
Since we are on the contentious subject of drugs and patents, it is worth pointing to another lively debate that has been going on in the blogosphere. In a nutshell, this is what it is about; Merck has a bestselling anti-HIV drug named Efavirenz. They offered to sell it to Brazil at a reduced price. [...]